Elanco Animal Health Incorporated [NYSE: ELAN] closed the trading session at $23.70 on 05/31/22. The day’s price range saw the stock hit a low of $23.42, while the highest price level was $24.1625. The company report on May 23, 2022 that Elanco to Participate in Stifel 2022 Jaws and Paws Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Stifel 2022 Jaws and Paws Conference on Wednesday, June 1, 2022. Jeff Simmons, president and CEO, will participate in a fireside chat at 3:00 p.m. ET.
A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days.
The stocks have a year to date performance of -16.49 percent and weekly performance of 0.04 percent. The stock has been moved at -21.50 percent over the last six months. The stock has performed -6.36 percent around the most recent 30 days and changed -18.11 percent over the most recent 3-months.
If compared to the average trading volume of 4.38M shares, ELAN reached to a volume of 9528219 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Elanco Animal Health Incorporated [ELAN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELAN shares is $31.57 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELAN stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Elanco Animal Health Incorporated shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on November 18, 2021. While these analysts kept the previous recommendation, Stifel dropped their target price from $37 to $34. The new note on the price target was released on October 28, 2021, representing the official price target for Elanco Animal Health Incorporated stock. Previously, the target price had yet another raise to $38, while Credit Suisse analysts kept a Outperform rating on ELAN stock.
The Average True Range (ATR) for Elanco Animal Health Incorporated is set at 0.88, with the Price to Sales ratio for ELAN stock in the period of the last 12 months amounting to 2.35. The Price to Book ratio for the last quarter was 1.52, with the Price to Cash per share for the same quarter was set at 0.73. Price to Free Cash Flow for ELAN in the course of the last twelve months was 41.05 with Quick ratio for the last quarter at 1.40.
ELAN stock trade performance evaluation
Elanco Animal Health Incorporated [ELAN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.04. With this latest performance, ELAN shares dropped by -6.36% in over the last four-week period, additionally sinking by -21.50% over the last 6 months – not to mention a drop of -33.24% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ELAN stock in for the last two-week period is set at 47.86, with the RSI for the last a single of trading hit 50.59, and the three-weeks RSI is set at 46.42 for Elanco Animal Health Incorporated [ELAN]. The present Moving Average for the last 50 days of trading for this stock 25.09, while it was recorded at 23.56 for the last single week of trading, and 28.65 for the last 200 days.
Elanco Animal Health Incorporated [ELAN]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Elanco Animal Health Incorporated [ELAN] shares currently have an operating margin of +6.34 and a Gross Margin at +43.55. Elanco Animal Health Incorporated’s Net Margin is presently recorded at -9.91.
Return on Equity for this stock declined to -5.89, with Return on Assets sitting at -2.76.
Elanco Animal Health Incorporated’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 2.40.
Earnings per share (EPS) analysis for Elanco Animal Health Incorporated [ELAN] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELAN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elanco Animal Health Incorporated go to 13.00%.
Elanco Animal Health Incorporated [ELAN]: Insider Ownership positions
There are presently around $11,292 million, in the hands of institutional investors. The top three institutional holders of ELAN stocks are: VANGUARD GROUP INC with ownership of 41,452,530, which is approximately 1.595% of the company’s market cap and around 0.40% of the total institutional ownership; PRICE T ROWE ASSOCIATES INC /MD/, holding 34,513,106 shares of the stock with an approximate value of $823.83 million in ELAN stocks shares; and PRIMECAP MANAGEMENT CO/CA/, currently with $734.82 million in ELAN stock with ownership of nearly 2.073% of the company’s market capitalization.
Positions in Elanco Animal Health Incorporated stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 240 institutional holders increased their position in Elanco Animal Health Incorporated [NYSE:ELAN] by around 36,322,138 shares. Additionally, 221 investors decreased positions by around 40,936,705 shares, while 80 investors held positions by with 395,811,097 shares. The mentioned changes placed institutional holdings at 473,069,940 shares, according to the latest SEC report filing. ELAN stock had 59 new institutional investments in for a total of 6,584,821 shares, while 64 institutional investors sold positions of 4,184,585 shares during the same period.